Effects of reduced exposure to cigarette smoking on changes in biomarkers of potential harm in adult smokers: results of combined analysis of two clinical studies

References

• Ambrose, J.A. and Barua, R.S., 2004. The pathophysiology of cigarette smoking and cardiovascular disease: an update. Journal of the American college of cardiology, 43 (10), 1731–1737.
   PubMed Web of Science ®Google Scholar
• Bito, R., et al., 2011. Exploratory study of smoking-specific biomarkers of effect in healthy adult smokers and non-smokers. The 32th annual scientific meeting of Japanese society of clinical pharmacology and therapeutics. (poster presentation; in Japanese). Hamamatsu: Japanese society of clinical pharmacology and therapeutics.
   Google Scholar
• Burchfiel, C.M., et al., 1995. Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. American journal of respiratory and critical care medicine, 151 (6), 1778–1785.
   PubMed Web of Science ®Google Scholar
• Calapai, G., et al., 2009. A cross-sectional investigation of biomarkers of risk after a decade of smoking. Inhalation toxicology, 21 (13), 1138–1143.
   PubMed Web of Science ®Google Scholar
• Health Canada, 1999. Determination of “tar,” nicotine and carbon monoxide in mainstream tobacco smoke-official method. Ottawa, Canada: Health Canada (SOR-2000-272).
   Google Scholar
• Cracowski, J.-L., et al., 2002. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends in pharmacological sciences, 23 (8), 360–366.
   PubMed Web of Science ®Google Scholar
• Cravo, A.S., et al., 2016. A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks. Regulatory toxicology and pharmacology, 81 (Suppl 1), S1–S14.
   PubMedGoogle Scholar
• Eliasson, B., et al., 2001. Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine & tobacco research, 3 (3), 249–255.
   PubMedGoogle Scholar
• FDA (Food and Drug Administration), 2012a. Guidance for industry — modified risk tobacco product applications—DRAFT GUIDANCE. Available from: https://www.fda.gov/media/83300/download
   Google Scholar
• FDA (Food and Drug Administration), 2012b. Guidance for industry – reporting harmful and potentially harmful constituents in tobacco products and tobacco smoke under section 904(a)(3) of the federal food, drug, and cosmetic act-draft guidance. Available from: https://www.fda.gov/TobaccoProducts/Labeling/RulesRegulationsGuidance/ucm297752.htm.
   Google Scholar
• Flores, L., et al., 2004. The effects of smoking and its cessation on 8-epi-PGF2alpha and transforming growth factor-beta 1 in Type 1 diabetes mellitus. Diabetic medicine, 21 (3), 285–289.
   PubMed Web of Science ®Google Scholar
• Frost-Pineda, K., et al., 2011. Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. Nicotine & tobacco research, 13 (3), 182–193.
   PubMed Web of Science ®Google Scholar
• Fujitani, T., et al., 2003. Effects of smoking on hematological parameters. Tokyo metropolitan institute of public health, 54, 370–375 [in Japanese].
   Google Scholar
• Garg, N., et al., 2006. Levels of lipid peroxides and antioxidants in smokers and nonsmokers. Journal of periodontal research, 41 (5), 405–410.
   PubMed Web of Science ®Google Scholar
• Halvorsen, B., et al., 2007. Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease. Scandinavian journal of clinical and laboratory investigation, 67 (6), 604–611.
   PubMed Web of Science ®Google Scholar
• Harman, S.M., et al., 2003. Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2)alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers. Free radical biology & medicine, 35 (10), 1301–1309.
   PubMed Web of Science ®Google Scholar
• Howard, G., et al., 1998. Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. JAMA, 279 (2), 119–124.
   PubMed Web of Science ®Google Scholar
• Ikonomidis, I., et al., 2018. Electronic cigarette smoking increases arterial stiffness and oxidative stress to a lesser extent than a single conventional cigarette: an acute and chronic study. Circulation, 137 (3), 303–306.
   PubMed Web of Science ®Google Scholar
• [IOM] Institute of Medicine Committee to Assess the Science Base for Tobacco Harm Reduction, 2001. Clearing the smoke: assessing the science base for tobacco harm reduction. Washington, DC: National Academies Press. Copyright 2001 by the National Academy of Sciences. All rights reserved
   Google Scholar
• International Organization for Standardization, 2000. Routine analytical cigarette smoking machine, ISO3308. Available from: https://www.iso.org/standard/28325.html
   Google Scholar
• Janssen, L.J., 2001. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. American journal of physiology. Lung cellular and molecular physiology, 280 (6), L1067–L1082.
   PubMed Web of Science ®Google Scholar
• Kakehi, A., et.al., 2012. Exposure to cigarette smoke constituents in adult Japanese smokers who switched to a non combustion inhaler type of tobacco. 2012 American College of Clinical Pharmacology Meeting. Sheraton San Diego Hotel & Marina.
   Google Scholar
• Kawada, T., et al., 2006. Study on characteristics of laboratory test value in smokers. Smoking research foundation [in Japanese].
   Google Scholar
• Kimm, H., et al., 2009. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke, 40 (11), 3422–3427.
   PubMed Web of Science ®Google Scholar
• Korchazhkina, O., et al., 2003. Measurement by reversed-phase high-performance liquid chromatography of malondialdehyde in normal human urine following derivatisation with 2,4-dinitrophenylhydrazine. Journal of chromatography. B, analytical technologies in the biomedical and life sciences, 794 (2), 353–362.
   PubMed Web of Science ®Google Scholar
• Lin, L.-Y., et al., 2009. Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents. Atherosclerosis, 203 (2), 563–568.
   PubMed Web of Science ®Google Scholar
• Ludicke, F., et al., 2015. A Japanese cross-sectional multicentre study of biomarkers associated with cardiovascular disease in smokers and non-smokers. Biomarkers, 20, 411–421.
   PubMed Web of Science ®Google Scholar
• Ludicke, F., et al., 2018. Effects of switching to the menthol tobacco heating system 2.2, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (part 2). Nicotine & tobacco research, 20, 173–182.
   PubMed Web of Science ®Google Scholar
• Martin Leroy, C., et al., 2012. Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 7: a one-month, randomized, ambulatory, controlled clinical study in Poland. Regulatory toxicology and pharmacology , 64 (2 Suppl), S74–S84.
   PubMed Web of Science ®Google Scholar
• Minami, J., et al., 2002. Effects of smoking cessation or alcohol restriction on metabolic and fibrinolytic variables in Japanese men. Clinical science (London, England: 1979), 103 (2), 117.
   PubMed Web of Science ®Google Scholar
• Miura, N., et al., 2013. Pharmacokinetic analysis of nicotine when using non-combustion inhaler type of tobacco product in Japanese adult male smokers. Regulatory toxicology and pharmacology , 67 (2), 198–205.
   PubMed Web of Science ®Google Scholar
• Miura, N., et al., 2015. A study to investigate changes in the levels of biomarkers of exposure to selected cigarette smoke constituents in Japanese adult male smokers who switched to a non-combustion inhaler type of tobacco product. Regulatory toxicology and pharmacology , 71 (3), 498–506.
   PubMed Web of Science ®Google Scholar
• Moriuchi, T., et al., 2010. Diabetes progression from "high-normal" glucose in school teachers. Internal medicine, 49 (13), 1271–1276.
   PubMed Web of Science ®Google Scholar
• Office of the Surgeon G., et al., 2004. Reports of the surgeon general. The health consequences of smoking: a report of the surgeon general. Atlanta, GA: Centers for Disease Control and Prevention.
   Google Scholar
• Ogden, M.W., et al., 2015. Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: part 3. Biomarkers of biological effect. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals, 20 (6–7), 404–410.
   PubMed Web of Science ®Google Scholar
• Ohara, H., et.al., 2014. A study of the changes of biomarkers for various types of tobacco in healthy adult male smokers. The 35th annual scientific meeting of Japanese society of clinical pharmacology and therapeutics (Poster Presentation; in Japanese). Ehime.
   Google Scholar
• Okuzono, H., et al., 1976. A spectrophotometric method for the determination of carboxyhemoglobin in blood, and some clinical reports (author's transl.). Rinsho byori the japanese journal of clinical pathology, 24, 616–621.
   PubMedGoogle Scholar
• O'Malley, S.S., et al., 2014. Smoking cessation is followed by increases in serum bilirubin, an endogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease. Nicotine & tobacco research, 16, 1145–1149.
   PubMed Web of Science ®Google Scholar
• Peck, M.J., et al., 2018. Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products. Biomarkers, 23(3), 213–244.
   PubMed Web of Science ®Google Scholar
• Polidori, M.C., et al., 2003. Cigarette smoking cessation increases plasma levels of several antioxidant micronutrients and improves resistance towards oxidative challenge. British journal of nutrition, 90 (1), 147–150.
   PubMed Web of Science ®Google Scholar
• Prieme, H., et al., 1998. Effect of smoking cessation on oxidative DNA modification estimated by 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion. Carcinogenesis, 19 (2), 347–351.
   PubMed Web of Science ®Google Scholar
• Rangemark, C., et al., 1993. Excretion of thromboxane metabolites in healthy women after cessation of smoking. Arteriosclerosis, thrombosis, and vascular biology, 13, 777–782.
   PubMed Web of Science ®Google Scholar
• Roethig, H.J., et al., 2008. A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. Journal of clinical pharmacology, 48 (5), 580–591.
   PubMed Web of Science ®Google Scholar
• Roethig, H.J., et al., 2010. Short term effects of reduced exposure to cigarette smoke on white blood cells, platelets and red blood cells in adult cigarette smokers. Regulatory toxicology and pharmacology, 57 (2–3), 333–337.
   PubMed Web of Science ®Google Scholar
• Saareks, V., et al., 2001. Effects of smoking cessation and nicotine substitution on systemic eicosanoid production in man. Naunyn-Schmiedeberg's archives of pharmacology, 363 (5), 556–561.
   PubMed Web of Science ®Google Scholar
• Scherer, G., 2018. Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: a literature review. Regulatory toxicology and pharmacology , 94, 203–233.
   PubMed Web of Science ®Google Scholar
• Sharrett, A.R., et al., 2001. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions. The Atherosclerosis Risk in Communities (ARIC) Study. Circulation, 104 (10), 1108–1113.
   PubMed Web of Science ®Google Scholar
• Soulimane, S., et al., 2014. HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis. Diabetologia, 57 (1), 30–39.
   PubMed Web of Science ®Google Scholar
• Stocker, R., et al., 1987. Bilirubin is an antioxidant of possible physiological importance. Science, 235 (4792), 1043.
   PubMed Web of Science ®Google Scholar
• Tsikas, D., 2017. Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges. Analytical biochemistry, 524, 13–30.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, 2010. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. Available from: https://www.ncbi.nlm.nih.gov/books/NBK53017/pdf/Bookshelf_NBK53017.pdf
   Google Scholar
• Van Hoydonck, P.G., et al., 2001. Serum bilirubin concentration in a Belgian population: the association with smoking status and type of cigarettes. International journal of epidemiology, 30 (6), 1465–1472.
   PubMed Web of Science ®Google Scholar
• Walele, T., et al., 2018. Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting. Regulatory toxicology and pharmacology, 92, 226–238.
   PubMed Web of Science ®Google Scholar
• Wannamethee, S.G., et al., 2005. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. European heart journal, 26 (17), 1765–1773.
   PubMed Web of Science ®Google Scholar